Red blood cell (erythrocyte) is the most abundant cellular component of blood and is specialized to transport respiratory gases between the lungs and tissues. Its primary cargo is oxygen bound to hemoglobin, while a substantial fraction of carbon dioxide is carried indirectly as bicarbonate after enzymatic conversion inside the cell. By circulating through capillary networks, red blood cells help maintain tissue metabolism and systemic acid–base balance. In most adult mammals, mature red blood cells lack a nucleus and most organelles, maximizing space for hemoglobin and flexibility for microvascular passage.
In healthy adults, typical red blood cell counts are about 4.2–5.4 million cells/µL in females and 4.7–6.1 million cells/µL in males, though reference ranges vary by lab and altitude. Hemoglobin concentration commonly ranges around 12.0–15.5 g/dL (females) and 13.5–17.5 g/dL (males), with hematocrit roughly 36–46% and 41–53%, respectively. A normal mean corpuscular volume (MCV) is about 80–100 fL, reflecting the average cell size used to classify anemias. These parameters integrate with Blood, Hemoglobin, and Oxygen transport physiology to determine overall oxygen delivery.
A typical human red blood cell is a biconcave disc about 7–8 µm in diameter and ~2 µm thick at the rim, a shape that increases surface area-to-volume ratio for gas exchange. The biconcavity also supports deformability, allowing cells to traverse capillaries narrower than their resting diameter. This mechanical resilience depends on a membrane skeleton built from spectrin, actin, ankyrin, and associated proteins that anchor to membrane channels and receptors. Disruption of these interactions can reduce deformability and shorten cell survival.
Hemoglobin dominates the cytoplasm, reaching an intracellular concentration on the order of ~33 g/dL of packed cells (MCHC typically ~32–36 g/dL). Each hemoglobin molecule can bind up to four oxygen molecules, and cooperativity enables efficient loading in the lungs and unloading in tissues. The red blood cell’s lack of mitochondria prevents it from consuming the oxygen it carries and forces reliance on anaerobic glycolysis for ATP. This design links red blood cell performance to Cell membrane integrity and the chemistry of Hemoglobin.
Red blood cell production, or erythropoiesis, occurs primarily in the bone marrow and is regulated by erythropoietin (EPO), a hormone largely produced by the kidneys in response to tissue hypoxia. Under steady-state conditions in adults, the bone marrow generates roughly 2 million red blood cells per second to replace senescent cells. Mature red blood cells circulate for about 120 days on average, after which they are cleared mainly by macrophages in the spleen and liver. This high-throughput renewal system keeps total red blood cell mass stable despite continuous loss.
Total red blood cell number in an adult human is commonly estimated at roughly 20–30 trillion cells, consistent with a blood volume of ~5 liters and counts near 5 million/µL. Daily turnover is therefore enormous: on the order of ~1/120 of the circulating pool each day, which aligns with the multi-million-per-second production rate. During increased demand (for example, after blood loss or at high altitude), EPO rises and reticulocyte output increases measurably within days. These dynamics intersect with Bone marrow function and the clinical interpretation of reticulocyte counts.
Oxygen transport depends on hemoglobin saturation, which is influenced by partial pressure of oxygen and factors such as pH, temperature, and 2,3-bisphosphoglycerate (2,3-BPG). The Bohr effect describes how lower pH and higher CO₂ promote oxygen unloading in metabolically active tissues. In the lungs, higher oxygen tension and a relatively higher pH favor oxygen loading. This reversible chemistry allows a small cell to act as a mobile reservoir of oxygen capacity.
For carbon dioxide, only a minority is carried directly bound to hemoglobin (carbaminohemoglobin), while a large fraction is transported as bicarbonate generated by carbonic anhydrase inside red blood cells. The chloride shift (exchange of bicarbonate for chloride) helps maintain electrical neutrality across the membrane during this process. Hemoglobin also buffers hydrogen ions, contributing significantly to blood’s overall buffering capacity. Together, these mechanisms make the red blood cell central to Acid–base balance and systemic homeostasis.
Disorders of red blood cells are among the most common clinical problems, frequently presenting as anemia (reduced oxygen-carrying capacity) or polycythemia/erythrocytosis (increased red cell mass). Anemia is typically evaluated using hemoglobin, hematocrit, red blood cell count, and indices such as MCV, mean corpuscular hemoglobin (MCH), and red cell distribution width (RDW). RDW is often around ~11.5–14.5% in many labs, and elevation can suggest mixed cell populations or evolving deficiency states. MCV classifies anemia broadly into microcytic (<80 fL), normocytic (80–100 fL), and macrocytic (>100 fL) patterns, each with characteristic differential diagnoses.
Iron deficiency anemia is a leading cause worldwide and commonly produces microcytosis and high RDW, while vitamin B12 or folate deficiency often produces macrocytosis. Hemolytic processes shorten red blood cell lifespan and can raise reticulocyte counts, bilirubin, and lactate dehydrogenase, whereas marrow failure can lower reticulocytes despite anemia. Polycythemia may be primary (myeloproliferative) or secondary to hypoxia-driven EPO increases, and it can increase blood viscosity and thrombosis risk. These conditions are often interpreted alongside Anemia and Spleen physiology, where clearance and sequestration influence circulating counts.
| Feature | Erythrocytes (RBCs) | Leukocytes (WBCs) |
|---|---|---|
| Primary function | Oxygen and CO₂ transport | Immune defence |
| Normal count (adult) | 4.5–6.5 million/μL (men); 3.8–5.8 million/μL (women) | 4,000–11,000/μL |
| Nucleus | Absent in mature cells (mammals) | Present |
| Haemoglobin | Yes — gives red colour | No |
| Lifespan | ~120 days | Hours to years (varies by type) |
| Size | 6–8 μm diameter, biconcave disc | 7–15 μm (varies by type) |
| Production site | Bone marrow (erythropoiesis) | Bone marrow, lymph nodes, thymus |
| Feature | Erythrocytes (RBCs) | Leukocytes (WBCs) |
|---|---|---|
| Primary function | Oxygen and CO₂ transport | Immune defence |
| Normal count (adult) | 4.5–6.5 million/μL (men); 3.8–5.8 million/μL (women) | 4,000–11,000/μL |
| Nucleus | Absent in mature cells (mammals) | Present |
| Haemoglobin | Yes — gives red colour | No |
| Lifespan | ~120 days | Hours to years (varies by type) |
| Size | 6–8 μm diameter, biconcave disc | 7–15 μm (varies by type) |
| Production site | Bone marrow (erythropoiesis) | Bone marrow, lymph nodes, thymus |
Myth: Red blood cells “carry oxygen dissolved in blood.” Reality: The vast majority of oxygen is transported bound to hemoglobin inside red blood cells, while only a small fraction is dissolved in plasma. This is why hemoglobin concentration is a much stronger determinant of oxygen content than oxygen partial pressure alone. In practical terms, severe anemia can critically reduce oxygen delivery even when lung oxygenation is normal.
Myth: Mature red blood cells are “complete cells like others.” Reality: In adult humans they are enucleated and lack mitochondria, ribosomes, and most organelles, which is unusual among body cells. This specialization improves deformability and maximizes hemoglobin content but limits repair capacity, contributing to the ~120-day lifespan. It also explains why red blood cells depend on glycolysis and are vulnerable to defects in metabolic enzymes and membrane proteins.
Myth: More red blood cells always improves athletic performance. Reality: While increased red cell mass can raise oxygen-carrying capacity, excessive elevation increases viscosity and can strain the cardiovascular system, raising risks such as hypertension and thrombosis. Adaptation to altitude can increase hematocrit, but the benefit is context-dependent and comes with tradeoffs. Clinical polycythemia illustrates that “more” can become pathologic rather than advantageous.
Myth: All red blood cells look identical and are interchangeable. Reality: Red blood cells vary in size and hemoglobinization, which is why indices like MCV and RDW are informative. Abnormal shapes (for example, spherocytes or sickled cells) can impair capillary flow and increase hemolysis, even if hemoglobin levels appear near-normal early on. Morphology on a peripheral smear remains a valuable window into red blood cell health and disease.